Sanofi to make priority with cardio sales reps, docs becomng more aware of benefits over Juxtapid,, and large ongoing trial that was granted an SPA from FDA intended to extend usage to much larger population.
There are no benefits over Juxtapid. The Sanofi treatment is cheaper because it doesn't work 1/2 as well, that is why they have to discount the price. This is all well documented in the clinical trials results. Why lie?